Skip to main content
. 2015 Sep 8;38(1):30–38. doi: 10.1590/1516-4446-2014-1516

Table 1. Sociodemographic characteristics, utility measures, and transition probabilities for children and adolescents in the base-case analysis.

Children (n=62)* Adolescents (n=28)
Age, mean ± standard deviation 8.62±1.7 13.67±1.61
Intelligence quotient, mean ± standard deviation 96.46±11.8 92.5±10.2
Male 46 (74.2) 25 (89.3)
Ethnicity
White 44 (71) 21 (80.8)
Stimulant-naïve 45 (72.6) 16 (59.3)
ADHD subtype
Combined 43 (69.4) 13 (46.4)
Inattentive 13 (21) 10 (35.7)
Hyperactivity/impulsivity 3 (4.8) 1 (3.6)
Subthreshold 3 (4.8) 4 (14.3)
Comorbidity
Oppositional defiant disorder 25 (40.3) 14 (50.0)
Conduct disorder 3 (4.8) 3 (10.7)
Anxiety disorder 5 (8.1) 5 (17.9)
Mood disorder 1 (1.6) 1 (3.6)
Transition probabilities
MPH-IR initiation 1.0 1.0
MPH-IR use, 4th week 0.7769 0.7697
MPH-IR success, 4th week 0.8941 0.9422
MPH-IR, probability of AE in non-success patients/24th week 0.406 0.321§
MPH-IR, probability of AE in success patients/24th week 0.333 0.091§
Spontaneous improvement, 24th week 0.09 0.09
Utility measures
Baseline utility 0.69 0.66
Utility gained with MPH-IR 0.10 0.09
Utility gained for spontaneous improvement 0.04 0.04
Disutility for AE ‐0.04 ‐0.04
Costs per month, I$ (range)
MPH-IR (WHO) 37.8 (0.00-150.00)
One consultation 5.37 (10.00-25.00)
Natural course 7.93 (0.00-150.00)
Discount per month 0.004265319

Data presented as n (%), unless stated otherwise.

ADHD = attention deficit hyperactivity disorder; AE = adverse event; MPH-IR = methylphenidate immediate release; WHO = World Health Organization.

All costs were converted to I$. The 2013 conversion factor is R$ 1.86. For more information, please visit The World Bank website (http://www.worldbank.org/).

*

62 children are the sum of 50 (baseline) plus 12 from ProDAH data set; 28 adolescents are the sum of 23 (baseline) plus 5 from ProDAH data set; number of children in the 24th week: 37; § number of adolescents in the 24th week: 19.